Energy XXI (EXXI) Bermuda Stock Declining After Posting Quarterly Loss

NEW YORK (TheStreet) -- Shares of Energy XXI Bermuda Ltd. (EXXI) are lower by 6.89% to $6.41 in mid-afternoon trading on Thursday, after the company reported a net loss for the fiscal 2015 first quarter of $9.3 million, or a loss of 10 cents per diluted share, compared to net income of $40.3 million, or 51 cents per diluted share for the year ago quarter.

The independent oil and natural gas exploration and production company said revenue increased to $403.2 million versus $324.6 million for the fiscal 2014 first quarter.

Analysts polled by Zacks Investment Research expected earnings of 7 cents per share on revenue of $406.5 million.

Separately, TheStreet Ratings team rates ENERGY XXI (BERMUDA) as a Hold with a ratings score of C. TheStreet Ratings Team has this to say about their recommendation:

"We rate ENERGY XXI (BERMUDA) (EXXI) a HOLD. The primary factors that have impacted our rating are mixed some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, feeble growth in the company's earnings per share and deteriorating net income."

You can view the full analysis from the report here: EXXI Ratings Report

EXXI Chart EXXI data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

More from Markets

Stocks Fall Hard as Earnings Disappoint, Caterpillar Tumbles

Stocks Fall Hard as Earnings Disappoint, Caterpillar Tumbles

Jim Cramer: If You're Afraid of the 10-Year Yield, Go to Cash

Jim Cramer: If You're Afraid of the 10-Year Yield, Go to Cash

Eli Lilly CEO Expresses Confidence in New Rheumatoid Arthritis Drug

Eli Lilly CEO Expresses Confidence in New Rheumatoid Arthritis Drug

Video: Jim Cramer on Rising Interest Rates, Trade Worries & Caterpillar

Video: Jim Cramer on Rising Interest Rates, Trade Worries & Caterpillar

Apple Suppliers Slide After European, Asian Chipmakers Echo Smartphone Concerns

Apple Suppliers Slide After European, Asian Chipmakers Echo Smartphone Concerns